TY - JOUR
T1 - Streptococcus agalactiae infects glial cells and invades the central nervous system via the olfactory and trigeminal nerves
AU - Chacko, Anu
AU - Delbaz, Ali
AU - Choudhury, Indra N.
AU - Eindorf, Tanja
AU - Shah, Megha
AU - Godfrey, Christopher
AU - Sullivan, Matthew J.
AU - St John, James A.
AU - Ulett, Glen C.
AU - Ekberg, Jenny A. K.
N1 - Publisher Copyright:
Copyright © 2022 Chacko, Delbaz, Choudhury, Eindorf, Shah, Godfrey, Sullivan, St John, Ulett and Ekberg.
PY - 2022/2/24
Y1 - 2022/2/24
N2 - Streptococcus agalactiae causes neonatal meningitis and can also infect the
adult central nervous system (CNS). S. agalactiae can cross the blood-brain
barrier but may also reach the CNS via other paths. Several species of bacteria
can directly invade the CNS via the
olfactory and trigeminal nerves, which extend between the nasal cavity and
brain and injury to the nasal epithelium can increase the risk/severity of
infection. Preterm birth is associated with increased risk of S. agalactiae infection
and with nasogastric tube feeding. The tubes, also used in adults, can cause
nasal injuries and may be contaminated with bacteria, including S. agalactiae. We
here investigated whether S.
agalactiae could invade the CNS after intranasal inoculation in mice. S. agalactiae rapidly
infected the olfactory nerve and brain. Methimazole-mediated model of nasal
epithelial injury led to increased bacterial load in these tissues, as well as
trigeminal nerve infection. S.
agalactiae infected and survived intracellularly in cultured
olfactory/trigeminal nerve- and brain-derived glia, resulting in cytokine
production, with some differences between glial types. Furthermore, a
non-capsulated S.
agalactiae was used to understand the role of capsule on glial cells
interaction. Interestingly, we found that the S. agalactiae capsule significantly altered
cytokine and chemokine responses and affected intracellular survival in
trigeminal glia. In summary, this study shows that S. agalactiae can infect the CNS via the
nose-to-brain path with increased load after epithelial injury, and that the
bacteria can survive in glia.
AB - Streptococcus agalactiae causes neonatal meningitis and can also infect the
adult central nervous system (CNS). S. agalactiae can cross the blood-brain
barrier but may also reach the CNS via other paths. Several species of bacteria
can directly invade the CNS via the
olfactory and trigeminal nerves, which extend between the nasal cavity and
brain and injury to the nasal epithelium can increase the risk/severity of
infection. Preterm birth is associated with increased risk of S. agalactiae infection
and with nasogastric tube feeding. The tubes, also used in adults, can cause
nasal injuries and may be contaminated with bacteria, including S. agalactiae. We
here investigated whether S.
agalactiae could invade the CNS after intranasal inoculation in mice. S. agalactiae rapidly
infected the olfactory nerve and brain. Methimazole-mediated model of nasal
epithelial injury led to increased bacterial load in these tissues, as well as
trigeminal nerve infection. S.
agalactiae infected and survived intracellularly in cultured
olfactory/trigeminal nerve- and brain-derived glia, resulting in cytokine
production, with some differences between glial types. Furthermore, a
non-capsulated S.
agalactiae was used to understand the role of capsule on glial cells
interaction. Interestingly, we found that the S. agalactiae capsule significantly altered
cytokine and chemokine responses and affected intracellular survival in
trigeminal glia. In summary, this study shows that S. agalactiae can infect the CNS via the
nose-to-brain path with increased load after epithelial injury, and that the
bacteria can survive in glia.
KW - astrocyte
KW - bacteria
KW - central nervous system
KW - olfactory ensheathing cell
KW - peripheral nerve
KW - Schwann cell
KW - Streptococcus agalactiae
UR - http://www.scopus.com/inward/record.url?scp=85126234419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126234419&partnerID=8YFLogxK
U2 - 10.3389/fcimb.2022.793416
DO - 10.3389/fcimb.2022.793416
M3 - Article
C2 - 35281448
AN - SCOPUS:85126234419
SN - 2235-2988
VL - 12
JO - Frontiers in Cellular and Infection Microbiology
JF - Frontiers in Cellular and Infection Microbiology
M1 - 793416
ER -